Koers Stemcell Holdings, Inc. Other OTC
Aandelen
STMM
US85858N2027
Farmaceutische producten
Omzet 2016 | 3,34 mln. 3,13 mln. | Omzet 2017 | 6,18 mln. 5,79 mln. | Marktkapitalisatie | 1,64 mln. 1,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | 1 mln. 936K | Nettowinst (verlies) 2017 | 2 mln. 1,87 mln. | EV/omzet 2016 * | - |
Nettoliquiditeiten 2016 * | - 0 | Nettoliquiditeiten 2017 * | - 0 | EV/omzet 2017 * | - |
K/w-verhouding 2016 * |
-
| K/w-verhouding 2017 * |
-
| Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 * |
-
| Vrij verhandelbaar | 99% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,87% | 94,22 mld. | |
-4,08% | 37,76 mld. | |
-13,94% | 32,5 mld. | |
+73,38% | 27,75 mld. | |
-11,46% | 16,13 mld. | |
-1,88% | 14,19 mld. | |
-11,67% | 11,42 mld. | |
+190,36% | 11,06 mld. | |
-52,61% | 9,09 mld. |